AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jon Koplik who wrote (1491)	6/6/2001
From: Mark Fowler	Read Replies (2) of 1728

Affymetrix, a maker of gene chips used by drug companies to trace the links between genes and disease, rose $5.40, or 12 percent, to close at $50.42 following an up-beat report by analyst Scott Greenstone of Thomas Weisel Partners. biz.yahoo.com Greenstone raised his recommendation to strong buy from buy, saying the company has ``entered a period of high profit growth.'' ``Affymetrix has 80 percent share of a market growing 50 percent annually,'' Greenstone said. ``We believe discovery is just beginning with indicators such as mass spectrometry exports, and customer calls clearly showing a continued ramp in discovery.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next